Accession Number: | 0001209191-22-038917 |
Date: | 2022-06-21 |
Issuer: | KURA ONCOLOGY, INC. (KURA) |
Original Submission Date: |
MALLEY THOMAS
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO, CA 92130
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION TO PURCHASE COMMON STOCK | 14.84 | 2022-06-21 | deemed execution date | A | 23,000 (a) | 2032-06-20 | common stock 23,000 | $14.84 | 23,000 | direct |
ID | footnote |
---|---|
f1 | this option vests in full on the one year anniversary of the date of grant. |